Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06885112 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser
A NA study of Hair Loss, sponsored by Lumenis Be.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06885112: Recruiting NA study of Hair Loss, sponsored by Lumenis Be.
NCT06885112 is a NA study of Hair Loss that is actively recruiting participants, run by Lumenis Be. The registered enrollment target is 40 participants, below the 1,351-participant average among 8 other Hair Loss trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06885112, a NA study of Hair Loss, is actively recruiting participants, sponsored by Lumenis Be.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The study incudes 18 to 55 y/o healthy subjects with moderate hair loss stage and Fitzpatrick skin type 5 or 6
Primary Outcome
The primary endpoint, the proportion of picture sets correctly classified as before/after by at least 2 of the 3 blinded reviewers, will be summarized by a count a percentage with exact two-sided 95% confidence interval. If the lower limit is greater than 70%, the null hypothesis will be rejected, and the endpoint will be deemed successfully met. There will be no formal interim statistical analysis.
Conditions Studied
Interventions
- DEVICE FoLix treatment for improving the scalp hair appearance
Study Locations (1)
New York
- UnionDerm - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-02-21 |
| Est. Completion | 2027-02-21 |
| Phase | NA |
What NCT06885112 shows while recruiting
NCT06885112 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,351-participant average among 8 other Hair Loss trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Hair Loss appearing as the primary indexed condition, and to 1 intervention - of which FoLix treatment for improving the scalp hair appearance is the first listed.
NCT06885112 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06885112 about?
NCT06885112 is a clinical study titled "Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser". The study incudes 18 to 55 y/o healthy subjects with moderate hair loss stage and Fitzpatrick skin type 5 or 6
What is the current status of trial NCT06885112?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-02-21. Estimated completion is 2027-02-21.
What conditions does trial NCT06885112 study?
This clinical trial studies the following conditions: Hair Loss.
What interventions are being tested in trial NCT06885112?
The interventions under investigation include: FoLix treatment for improving the scalp hair appearance (DEVICE).
Who is sponsoring clinical trial NCT06885112?
This trial is sponsored by Lumenis Be, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06885112 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hair Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06885112's enrollment target sits among peer trials
40 5th of 8 higher than 3 of 8 other Hair Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hair Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
RECRUITING · NA
-
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
RECRUITING · NA
-
A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
ACTIVE NOT RECRUITING · NA
-
A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health
COMPLETED · NA
-
Impact of a Topical Cosmetic Product on Women's Hair
COMPLETED · NA
-
Blood Specimen Collection For Laboratory Assay Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI